Wacker Biotech

Engage the CDMO Experts in Advanced Therapies & Biologics Manufacturing

We are passionate about working closely with our customers to develop the next generation of advanced therapeutics, for the benefit of treating, curing, and preventing diseases for patients worldwide.

A Global CDMO backed by a science-driven Powerhouse

Your needs are driving our innovation! Our five GMP-compliant facilities located in Germany, the Netherlands and United States are closely supported by the corporate R&D team of our parent company Wacker Chemie AG. In close collaboration with universities and research institutions, this team of more than 180 researchers innovates new technologies and partnerships. Competitive, outstanding solutions are our trademarks.

years of Experience

Batches On-Time and On-Budget

Innovative Production Platforms

Client Projects

Active Patents and Applications

News

Engage the Experts for

Science-Driven Solutions

Your biologics come to life with the help of our many scientists including a central R&D team and E. coli-based technology platforms that significantly increase bioprocess efficiency, reducing cost of goods and speeding time to market.

Guidance from Concept to Commercialization

Experience seamless drug development with single source expert navigation. We've successfully managed multiple programs from feasibility studies and process development through to clinical testing and EMA/FDA-approved manufacturing for the commercial market.

A Flexible Partner who Delivers

In Wacker Biotech you have a long-term partner committed to agile, transparent communication and dedicated to your project’s success. Backed by a 112-year-old parent company committed to ongoing biotech capital investments.